Cookies 🍪

Diese Website verwendet Cookies, die Ihre Zustimmung brauchen.

Employee photo Ms. Ana Grönke

Ana Grönke (Dr. rer. nat.)

Projektkoordinator / Datenverwalter / wissenschaftlicher Mitarbeiter an der Universität zu Köln
ORCID: 0009-0006-9447-7687

Biografie

Ana Grönke ist Wissenschaftlerin mit einem Master-Abschluss in Biologie (Universität Belgrad), einem Magister-Abschluss in Pflanzenphysiologie und Genetik (Universität Belgrad), einem Doktortitel in Medizinwissenschaften (Karolinska-Institut, Schweden) und einer Postdoc-Tätigkeit mit Schwerpunkt auf mitochondrialen Funktionsstörungen bei menschlichen Erkrankungen (Max-Planck-Institut für Biologie des Alterns, Köln). Sie verfügt über umfangreiche Erfahrung in der Leitung internationaler interdisziplinärer Teams und der Führung kleiner Teams.

Kontakt

Fachliche Ausbildung

Fachgebiete

Publikationen Ana Grönke

Seeing the primary tumor because of all the trees: Cancer type prediction on low-dimensional data

2024 - Open Access -
Julia Gehrmann, Devina Johanna Soenarto, Kevin Hidayat, Maria Beyer, Lars Quakulinski, Samer Alkarkoukly, Scarlett Berressem, Anna Gundert, Michael Butler, Ana Grönke, Simon Lennartz, Thorsten Persigehl, Thomas Zander, Oya Beyan

The Cancer of Unknown Primary (CUP) syndrome is characterized by identifiable metastases while the primary tumor remains hidden. In recent years, various data-driven approaches have been suggested to predict the location of the primary tumor (LOP) in CUP patients promising improved diagnosis and outcome. These LOP prediction approaches use high-dimensional input data like images or genetic data. However, leveraging such data is challenging, resource-intensive and therefore a potential translational barrier. Instead of using high-dimensional data, we analyzed the LOP prediction performance of low-dimensional data from routine medical care. With our findings, we show that such low-dimensional routine clinical information suffices as input data for tree-based LOP prediction models. The best model reached a mean Accuracy of 94% and a mean Matthews correlation coefficient (MCC) score of 0.92 in 10-fold nested cross-validation (NCV) when distinguishing four types of cancer. When considering eight types of cancer, this model achieved a mean Accuracy of 85% and a mean MCC score of 0.81. This is comparable to the performance achieved by approaches using high-dimensional input data. Additionally, the distribution pattern of metastases appears to be important information in predicting the LOP.